Pharmacogenetic Study in Hepatocellular Carcinoma Patients.

NCT05291338 · clinicaltrials.gov ↗

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Doxorubicin
DRUG: Lipiodol

Sponsor

Rehab Werida